PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 16, 2026Journal of Clinical Medicine0 citationsOpen Access

Correction: Ignat et al. Antiviral Therapy of Chronic Hepatitis B Virus between Present and Future. J. Clin. Med. 2024, 13, 2055

View Full Paper
MIMariana Daniela IgnatABAlexia Anastasia Ștefania BaltaRBRaisa Eloise Barbu

Key Points

  • To examine the current and future antiviral therapies for managing chronic hepatitis B virus infections.
  • Review of recent literature on antiviral therapies.
  • Analysis of treatment protocols and their effectiveness.
  • Evaluation of biomarkers relevant to chronic hepatitis B.
  • Advancements in antiviral medications demonstrate improved outcomes.
  • Future therapies show promise in enhancing patient management.
  • Biomarkers can help tailor treatment approaches effectively.

Abstract

References ...

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Ignat et al. (2026) studied this question.

synapsesocial.com/papers/69e07dc72f7e8953b7cbeb19https://doi.org/10.3390/jcm15082970
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Antiviral Therapy of Chronic Hepatitis B Virus between Present and Future2024 · 16 citations
  2. 2Diagnostic and Management of Undescended Ovary – A Preoperative Dilemma: A Case-Based Systematic Review2022 · 19 citations
  3. 3Diagnostic and Management of Undescended Ovary – A Preoperative Dilemma: A Case-Based Systematic Review2022 · 23 citations
  4. 4Prevention of recurrent hepatitis B virus infection after liver transplantation: hepatitis B immunoglobulin, antiviral drugs, or both? Systematic review and meta-analysis2009 · 101 citations
  5. 5A Comparison of Entecavir and Lamivudine for HBeAg-Positive Chronic Hepatitis B2006 · 1,450 citations